We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Wearable Biomedical Device Helps Combat Diabetes

By LabMedica International staff writers
Posted on 05 Apr 2016
Print article
Image: The GP-hybrid electrochemical device array (Photo courtesy of IBS Center for Nanoparticle Research).
Image: The GP-hybrid electrochemical device array (Photo courtesy of IBS Center for Nanoparticle Research).
An innovative graphene-based patch is capable of noninvasive blood sugar monitoring and feedback therapy by analyzing human sweat.

Developed by researchers at the Institute for Basic Science (IBS; Daejeon, Republic of Korea) the patch integrates electrochemically-active and soft functional materials on a gold-doped graphene and serpentine-shape gold mesh hybrid patch. The enzyme-based glucose sensor also enables systematic corrections of sweat glucose measurements as affected by pH and temperature, while a humidity sensor monitors the increase in relative humidity (RH). About 15 minutes are needed for the sweat-uptake layer of the patch to reach a RH over 80%, at which time glucose and pH measurements are initiated.

If abnormally high levels of glucose are detected, drugs can be released into the bloodstream via loaded microneedles. In an experiment to test the patch on diabetic mice, microneedles pierced the skin of the mouse near the abdomen, releasing Metformin into the bloodstream. The mice treated with microneedles showed a significant suppression of blood glucose concentrations with respect to control groups. The malleable, semi-transparent, skin-like appearance of the GP device also provides comfortable contact with human skin. The study was published on March 22, 2016, in Nature Nanotechnology.

“Our wearable GP-based device is capable of not only sweat-based glucose and pH monitoring, but also controlled transcutaneous drug delivery through temperature-responsive microneedles,” said lead author Kim Dae-Hyeong, PhD, of the IBS Center for Nanoparticle Research. “One can easily replace the used microneedles with new ones. Treatment with Metformin through the skin is more efficient than that through the digestive system because the drug is directly introduced into metabolic circulation.”

Type II diabetes affects some three million Koreans, with the figure increasing due to dietary patterns and an aging society. The current treatments available to diabetics are painful, inconvenient and costly, and regular visits to a doctor and home testing kits are needed to record glucose levels. Patients also have to inject uncomfortable insulin shots to regulate glucose levels. According to IBS, the device could facilitate the process and reduce lengthy and expensive cycles of visiting doctors and pharmacies.

Related Links:

Institute for Basic Science


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.